Cargando…
Pharmacogenetics of Anticoagulation and Clinical Events in Warfarin-Treated Patients: A Register-Based Cohort Study with Biobank Data and National Health Registries in Finland
PURPOSE: To assess the association between VKORC1 and CYP2C9 variants and the incidence of adverse drug reactions in warfarin-treated patients in a real-world setting. MATERIALS AND METHODS: This was a register-based cohort study (PreMed) linking data from Finnish biobanks, national health registrie...
Autores principales: | Vuorinen, Anna-Leena, Lehto, Mika, Niemi, Mikko, Harno, Kari, Pajula, Juha, van Gils, Mark, Lähteenmäki, Jaakko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7954279/ https://www.ncbi.nlm.nih.gov/pubmed/33727862 http://dx.doi.org/10.2147/CLEP.S289031 |
Ejemplares similares
-
Integrating data from multiple Finnish biobanks and national
health-care registers for retrospective studies: Practical
experiences
por: Lähteenmäki, Jaakko, et al.
Publicado: (2021) -
Use of Home Telemonitoring to Support Multidisciplinary Care of Heart Failure Patients in Finland: Randomized Controlled Trial
por: Vuorinen, Anna-Leena, et al.
Publicado: (2014) -
Genetic Testing Before Anticoagulation? A Systematic Review of Pharmacogenetic Dosing of Warfarin
por: Kangelaris, Kirsten Neudoerffer, et al.
Publicado: (2009) -
Warfarin Anticoagulant Therapy: A Southern Italy Pharmacogenetics-Based Dosing Model
por: Mazzaccara, Cristina, et al.
Publicado: (2013) -
Warfarin-related nephropathy: possible role for the warfarin pharmacogenetic profile
por: Di Maso, Vittorio, et al.
Publicado: (2014)